Is the Mental Health Market growing now?

Why does the Mental Health Market look hot and broken at the same time?

The Mental Health Market is growing today, but the strongest growth is concentrated in clinical care that insurers, employers and health systems can actually pay for.

That distinction clears up much of the confusion around the market. For this analysis, we are looking at therapy, psychiatry, provider networks, employer mental health benefits, clinically oriented digital care and emerging AI mental health products. We are not stretching the definition to include the entire wellness economy.

Several large mental health companies are reaching a scale that would have been unusual a few years ago. Headway currently lists more than 80,000 therapists and psychiatrists and says more than 40 million sessions have been completed through its network. Grow Therapy facilitated seven million therapy and medication-management visits in 2025 and now works with more than 26,000 providers. Talkiatry has passed three million patient visits while employing more than 800 psychiatrists.

At the same time, the old consumer-subscription story looks weak. BetterHelp's latest quarter produced $212.6 million in revenue, down 12% year over year, and its adjusted EBITDA margin fell to just 0.2%. Teladoc has now lowered its full-year BetterHelp outlook and explicitly says it is putting more emphasis on insurance-covered services.

That split gives us the central question for the rest of the article. Mental health demand remains huge, but the market has become much more selective about how that demand turns into revenue. Companies that help patients use insurance, find clinicians, obtain psychiatry or move through the healthcare system are growing. Charging consumers hundreds of dollars directly for a therapy subscription has become much harder.

If you want more recent data on this point, please see our latest mental health market report.

Is mental illness itself getting worse right now?

Mental illness prevalence is not currently rising enough to explain the growth we are seeing in the Mental Health Market.

The newest national data make this surprisingly clear. SAMHSA's 2025 National Survey on Drug Use and Health estimated that 20.6% of U.S. adults had a mental illness during the year, representing about 54.6 million people. In 2024, the comparable figure was 21.5%.

Young adults moved even further in the opposite direction. Mental illness among people aged 18 to 25 was estimated at 28.6% in 2025, compared with 31.9% a year earlier. Serious mental illness affected 6.9% of all adults.

One year of survey movement does not mean America's mental health problems are disappearing. The more useful finding is that prevalence remains broadly stable at an extremely high level rather than suddenly accelerating.

That changes how we read the commercial growth. When companies process millions more appointments while the percentage of adults with mental illness stays roughly flat, more of the business is coming from people accessing treatment, using insurance more effectively or moving into organized provider networks.

The Mental Health Market therefore has room to grow without another increase in mental illness. Tens of millions of people already need care.

If mental illness is not rising, where is the extra Mental Health Market demand coming from?

The Mental Health Market can keep growing because roughly half of U.S. adults with a mental illness still receive no mental health treatment.

According to SAMHSA's newest survey, only 50.9% of adults with any mental illness received treatment in 2025. Among people with serious mental illness, treatment penetration reached 67.7%, which still leaves almost one-third untreated.

The reasons are unusually useful for understanding the commercial opportunity. Among adults who felt they needed treatment but did not receive it, 61.4% said treatment would cost too much, 48.3% said they lacked enough time, 44.9% did not know how or where to obtain treatment, and 43.2% could not find a program or professional they wanted to use.

The provider shortage makes that access problem harder. HRSA reported that roughly 137 million Americans lived in a designated mental-health professional shortage area at the end of 2025, around 40% of the population. More recent federal shortage-area data continue to show thousands of designated mental-health shortage areas.

This helps explain why companies that make existing clinicians easier to find and easier to reimburse can grow so quickly. They do not need to create a new mental-health condition or persuade someone that therapy exists. They need to solve very ordinary problems: "Who accepts my insurance?", "Can I see someone this week?", "How much will it cost?", and "Can my doctor refer me directly?"

Those sound simple. The treatment-gap numbers show that the healthcare system still handles them badly.

Mental health access measure	Latest U.S. finding
Adults with any mental illness	54.6M
Adults with mental illness receiving treatment	50.9%
Adults with serious mental illness receiving treatment	67.7%
Untreated people citing cost	61.4%
Untreated people citing lack of time	48.3%
Untreated people unsure where to get care	44.9%
Population living in mental-health shortage areas	~137M

Did teletherapy fade after the pandemic?

Teletherapy has clearly survived, although the newest data suggest that virtual mental health usage has settled into a large plateau rather than continuing to surge.

SAMHSA counted 32.6 million U.S. adults receiving mental health treatment through telehealth in 2025. The previous year was 33.4 million. As a share of all adults, usage moved from 12.8% to 12.3%, a difference that SAMHSA did not find statistically significant.

Among adults who actually had a mental illness, nearly one-third received treatment through telehealth. For serious mental illness, the figure was 46.0%.

Those numbers tell us more than another teletherapy funding announcement. More than 30 million adults are still using virtual mental healthcare each year, several years after the emergency conditions that initially accelerated adoption.

The technology itself has become almost boring, which is probably a sign of maturity. Patients increasingly move between video, messaging and in-person appointments without treating "telehealth" as a separate category. Headway, for example, lets patients choose virtual or physical appointments inside the same insurance-based marketplace.

Teletherapy is no longer giving the Mental Health Market a one-off pandemic growth boost. It now acts as a permanent delivery channel that makes a much larger provider network reachable.

Less spectacular than the original telehealth boom, yes. Commercially, probably more durable.

If you want more recent data on this point, please see our latest mental health market report.

Are employers still spending more on mental health?

Large employers are still seeing mental health utilization rise, and mental healthcare is now expensive enough to show up as a meaningful healthcare cost driver.

Business Group on Health surveyed 121 major employers covering 11.6 million lives for its 2026 healthcare strategy research. Seventy-three percent said they were already experiencing increased use of mental-health and substance-use services, while another 17% expected utilization to rise.

So nine employers in ten either see higher use already or expect more.

Mental health also appeared among the three largest healthcare cost drivers for 18% of surveyed employers. Access remains a priority: 69% ranked mental-health access among their three biggest mental-health concerns, 72% planned to offer free or low-cost virtual counseling, and 44% were working with health plans or vendors to expand their mental-health networks.

The interesting change is how employers talk about the category. For several years, the priority was simply getting employees to use mental-health services. Now employers are asking whether the treatment is appropriate, whether provider quality is good and whether vendors can prove outcomes.

Business Group on Health's newer well-being research reaches the same broad conclusion. Employers remain committed to well-being programs, but rising healthcare costs have made them more demanding with vendors.

That should favor mental-health companies delivering actual treatment over companies selling another engagement layer. An employer can justify spending on therapy or psychiatry when employees are using the service and outcomes can be measured. A generic wellness app with low utilization has a much tougher argument today.

Are insurers becoming the real growth engine in digital mental health?

Yes. Insurance is now one of the clearest growth engines in digital mental health, and the shift can be measured directly inside companies that previously relied heavily on consumers.

Talkspace provides the cleanest example. In 2025, total revenue increased 22% to $228.9 million. Payor revenue jumped 37.9% to $171.5 million, while consumer revenue fell 29.5% to only $17.5 million.

That is an enormous change in revenue mix. Payors generated almost ten times as much Talkspace revenue as direct consumers during the year.

The same insurance-first logic sits at the center of several private companies. Grow Therapy now works with more than 125 health plans that give approximately 220 million Americans access to its network. Headway works with more than 100 insurance plans. Talkiatry is in-network with more than 100 insurers covering over 170 million lives.

The appeal is straightforward from the patient's side. Grow says an insured session costs its clients about $21 on average, with roughly one-third paying nothing. Compare that with paying hundreds of dollars directly every month for therapy and it becomes easier to understand where the demand goes.

Insurance also creates harder businesses to build. Companies need credentialing operations, claims infrastructure, reimbursement contracts, clinician networks and relationships with large payers. Those capabilities take longer to assemble than an app.

The current Mental Health Market increasingly looks like healthcare infrastructure delivered through software. That is less fashionable than "digital therapy," but it fits the economics better.

If you want more recent data on this point, please see our latest mental health market report.

Which mental health companies are actually reaching serious scale?

Several mental health companies have now reached enough patients, providers and appointments that we can measure a real operating market rather than extrapolate from funding rounds.

Grow Therapy is the clearest growth example. The Financial Times and Statista ranked Grow first among the Americas' fastest-growing companies in their 2026 ranking after verified revenue increased from $3.6 million in 2021 to $617.4 million in 2024. That works out to a 455.6% annualized growth rate. Grow then reported seven million appointments during 2025, compared with ten million across its entire lifetime.

Headway shows a different kind of scale. Its live marketplace now lists more than 80,000 licensed providers, more than 40 million completed sessions and relationships with more than 100 insurance plans. The company had reported more than 65,000 providers for 2025, so the network has continued expanding since then.

Talkiatry gives us another useful comparison because psychiatry is much harder to scale than general wellness or coaching. The company now employs more than 800 full-time psychiatrists, has delivered over three million visits and works with more than 50 health systems. Its revenue grew 1,745% between 2021 and 2024, according to figures released alongside its latest financing.

Spring Health is also moving into a larger league. Kinnevik, one of its investors, reported that Spring had grown revenue at more than 80% annually over the previous three years, had remained profitable through 2025 and covered more than 50 million people.

These companies use different models, which makes the pattern more convincing. Growth is showing up in provider marketplaces, psychiatry, employer care and insurance infrastructure rather than depending on one lucky company.

Company	Recent operating scale	What is growing
Grow Therapy	7M visits in 2025; 26,000+ providers	Insured therapy and psychiatry
Headway	80,000+ providers; 40M+ sessions	Insurance-based provider network
Talkiatry	800+ psychiatrists; 3M+ visits	In-network psychiatry
Spring Health	50M+ covered lives	Employer and health-plan mental healthcare

Is BetterHelp showing that the old digital mental health model is broken?

BetterHelp's current numbers make a strong case that large cash-pay therapy subscriptions are struggling even while the broader Mental Health Market grows.

BetterHelp generated $950.4 million of revenue in 2025, down 9%. The decline has become steeper this year. Revenue fell 10% in the first half and 12% in the latest quarter, while quarterly adjusted EBITDA dropped 96% to just $471,000.

Teladoc has responded by cutting its BetterHelp revenue forecast and putting more attention on insurance-covered services. The company now expects the segment to shrink by roughly 13% to 19% for the full year.

Talkspace went through a very similar shift before being acquired: consumer revenue fell almost 30% during 2025 while its payor business grew almost 38%.

Two large online-therapy businesses reaching the same outcome tells us more than either company alone. The product is useful and consumers still want remote therapy, yet getting people to pay the full recurring price themselves is increasingly difficult when insured alternatives are becoming easier to find.

Customer acquisition makes the model painful too. A cash-pay platform must repeatedly find people willing to spend meaningful amounts of their own money, then keep them engaged long enough to recover marketing costs while continuing to pay clinicians.

Insurance changes the equation. The patient sees a much smaller price, treatment can continue for longer, and the platform taps into healthcare dollars that employers and insurers were already spending.

The weak BetterHelp numbers do not undermine the entire Mental Health Market. They narrow the answer considerably: one of the market's most visible early business models is losing ground while reimbursed mental healthcare takes share.

If you want more recent data on this point, please see our latest mental health market report.

Are investors really coming back to mental health startups?

Investors are putting serious money into mental health again, but the current funding market strongly favors companies that have already proved they can deliver care at scale.

Rock Health counted $7.4 billion of U.S. digital-health venture funding across 244 deals in the first half of 2026. That was $1 billion more than during the same period a year earlier, with almost exactly the same number of deals.

Mental health remained the most heavily funded clinical indication for the seventh consecutive year.

The concentration is important. Deals worth at least $100 million represented 45% of all digital-health capital deployed during the half, even though they accounted for only a little over 8% of financing rounds. Investors are writing bigger checks to fewer companies.

Mental health fits that pattern very well. Talkiatry raised $210 million and Grow Therapy raised $150 million. Other recent rounds broaden the picture: Slingshot AI raised $93 million around its Ash conversational mental-health product, Salma Health raised $80 million, Click Therapeutics raised $50 million and youth mental-health company Somethings raised $19 million.

This feels very different from the 2021 funding market. A mental-health startup can still raise a huge round, but "mental health is a massive problem" is no longer enough of a pitch. The biggest financings are going toward psychiatry networks, insurance-connected platforms, specialized care or technology with a more specific clinical role.

That makes today's funding recovery more credible as a market indicator. Capital is increasingly following demonstrated utilization and distribution instead of assuming that every mental-health app will become a large company.

Are big healthcare companies actually buying mental health platforms now?

Yes. Mental health platforms are now valuable enough for traditional healthcare groups to buy them as core infrastructure rather than leave virtual care sitting outside the health system.

The freshest example is Universal Health Services' $835 million acquisition of Talkspace, which has now closed. UHS already runs one of the country's largest networks of behavioral-health hospitals and outpatient facilities. Talkspace adds roughly 6,000 licensed virtual providers and access to more than 200 million people through health plans, employers and other programs.

Talkspace had already become heavily dependent on payor revenue. That makes the acquisition strategically logical: UHS can connect lower-acuity virtual therapy and psychiatry with outpatient programs, crisis care and inpatient treatment inside one behavioral-health system.

Spring Health's deal for Alma points in the same direction from another angle. Spring built distribution through employers and health plans, while Alma built infrastructure that helps independent therapists handle insurance and practice management. Kinnevik reported that the combined business is targeting around $1 billion of revenue in the year following the merger.

The broader M&A numbers are active without looking manic. Trilliant Health counted 111 mental-health transactions in 2025, compared with 108 in 2024. Across digital health more broadly, Rock Health recorded 115 acquisitions during the first half of 2026, with the second quarter becoming the busiest acquisition quarter since 2021.

So consolidation is not simply happening because hundreds of failed therapy apps need buyers. Large healthcare organizations are deliberately combining virtual care, clinician networks, insurance relationships and physical facilities.

Mental health is becoming part of the healthcare stack.

Are AI mental health chatbots becoming a real market?

AI mental health is becoming a real commercial category now, although clinical evidence is still much thinner than consumer adoption.

The behavioral change is already happening. Rock Health's consumer research found that use of AI chatbots for health information doubled from 16% to 32% in one year. ChatGPT alone accounted for 23% of respondents, far ahead of chatbots supplied by healthcare providers or insurers.

Pew Research found a lower overall number using a different question, but the age pattern was striking: 32% of adults aged 18 to 29 said they sometimes used AI chatbots for health information. Mental health is an obvious use case because conversation itself is central to the product.

Purpose-built companies are now attracting substantial capital. Slingshot AI raised $93 million to build Ash, a conversational AI designed specifically for mental health. Existing mental-health providers are also embedding AI into documentation, patient support and care navigation.

We finally have some clinical evidence too. A randomized trial published in NEJM AI tested Dartmouth's Therabot with 210 adults experiencing clinically significant depression, anxiety or elevated eating-disorder risk. After four weeks, people using Therabot improved significantly more than the control group. The reported effect sizes were large, ranging from roughly 0.63 to 0.90 depending on the condition and measurement point.

Confidence should stay lower here than in the therapy-network sections. One 210-person trial cannot prove that AI therapy works safely across millions of people, especially for patients facing crises, psychosis or complicated diagnoses.

Still, the market question has changed. AI mental-health products now have real consumer usage, venture funding and randomized clinical evidence behind them.

The more likely near-term model is AI working around clinicians rather than eliminating them. Screening, between-session support, documentation, navigation and lower-acuity coaching can expand capacity without asking an unsupervised chatbot to handle every clinical decision.

What could actually stop the Mental Health Market from growing?

The biggest threat to Mental Health Market growth is no longer lack of demand. It is whether companies can turn that demand into affordable care with acceptable economics.

Cost remains the first constraint. SAMHSA found that 61.4% of adults with an unmet treatment need cited treatment being too expensive. Employers face the same pressure from the other side: Business Group on Health expects overall healthcare costs to keep rising sharply, so mental-health vendors have to prove that their programs justify the bill.

Reimbursement creates another tension. Insurance has become a major growth engine, but insurers control rates and impose credentialing, claims and documentation requirements. A company can process millions of appointments and still struggle if reimbursement barely covers clinicians, operations and customer support.

The workforce shortage cuts both ways too. It creates enormous demand for companies that improve access, while the limited supply of psychiatrists and therapists puts a ceiling on how fast human care can expand.

Quality is becoming harder to ignore. Employers increasingly want clinical outcomes rather than engagement statistics, and health systems buying mental-health platforms have more reputational risk than venture-backed apps did during the early digital-health boom. That raises the bar for every provider network.

AI adds the least predictable risk. Good clinical evidence could open a massive low-cost treatment layer. A serious safety failure, aggressive regulation or evidence that users receive worse care could slow that market very quickly.

The Mental Health Market has plenty of demand available, but future growth will reward companies that solve healthcare economics rather than companies that merely attract attention.

Is the Mental Health Market growing now?

Yes. The Mental Health Market is growing now, and the evidence is strong enough for us to call the claim mostly true rather than speculative.

The crucial point is where the growth sits.

Mental illness prevalence itself is broadly stable. Teletherapy usage has also settled at a high level instead of continuing its pandemic surge. And the cash-pay consumer therapy model is clearly having a difficult time.

Meanwhile, several harder commercial indicators keep moving in the other direction. Insured provider networks now contain tens of thousands of clinicians. Mental-health platforms are processing millions of appointments. Large employers continue to report higher service utilization. Mental health remains the top-funded digital-health clinical indication. Psychiatry companies are raising nine-figure rounds. Major healthcare groups are buying virtual mental-health infrastructure and connecting it to physical healthcare systems.

We can also see why this growth still has room to continue. Roughly half of U.S. adults with a mental illness receive no treatment, cost remains a major barrier and around 137 million people live in areas officially designated as having mental-health provider shortages.

The weaker part of the market gives us almost as much information as the stronger part. BetterHelp's contraction and the decline of direct consumer revenue elsewhere show that willingness to seek mental healthcare does not automatically translate into willingness to pay the full cost personally.

The businesses winning today increasingly solve that problem through insurance, employer benefits, provider networks and health-system distribution.

AI could add another large layer, but we would keep that part of the conclusion provisional. Consumer adoption is already meaningful and the first clinical trial results are encouraging, while safety, regulation and reliable reimbursement remain unresolved.

Our final judgment is fairly sharp: the Mental Health Market is currently growing, but the growth is becoming more medical, more reimbursed and more concentrated around scaled care providers. The 2021 idea of digital mental health centered on consumer apps. The market forming now looks much closer to a permanent piece of the healthcare system.

Test	What the current evidence says	Verdict
Is mental illness prevalence accelerating?	Latest adult prevalence declined slightly	No
Is there still a large untreated population?	About half of adults with mental illness receive no treatment	Yes
Is teletherapy still widely used?	More than 32M U.S. adults use it annually	Yes
Are employers seeing more mental-health utilization?	73% already see an increase; another 17% expect one	Yes
Are insurance-based platforms scaling?	Tens of thousands of providers and millions of annual visits	Strongly yes
Is cash-pay subscription therapy growing?	BetterHelp revenue continues to contract	No
Is venture capital returning?	Mental health remains digital health's top-funded clinical indication	Yes
Are healthcare incumbents buying mental-health platforms?	A major $835M acquisition has just closed	Yes
Is AI mental health already proven at scale?	Early clinical evidence is promising, but still limited	Too early
Overall	Growth is real and increasingly concentrated in reimbursed clinical care	Mostly true

If you want more recent data on this point, please see our latest mental health market report.

Who is the author of this content?

NEW MARKET PITCH TEAM

We track new markets so founders and investors can move faster

We build living "market pitch" documents for emerging markets: AI, synthetic biology, new proteins, and more. Instead of outdated PDFs or hallucinated LLM answers, our clients get a clean, visual, always-updated view of what's really happening: key players, deals, regulations, and signals that matter. Learn more about us.